"Receptor, TIE-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A TIE receptor found predominantly on ENDOTHELIAL CELLS. It is considered essential for vascular development and can form a heterodimer with the TIE-2 RECEPTOR. The TIE-1 receptor may play a role in regulating BLOOD VESSEL stability and maturation.
| Descriptor ID |
D042810
|
| MeSH Number(s) |
D08.811.913.696.620.682.725.400.925.249 D12.776.543.750.630.687.249
|
| Concept/Terms |
Receptor, TIE-1- Receptor, TIE-1
- Receptor, TIE 1
- TIE-1 Receptor
- TIE-1 Receptor Tyrosine Kinase
- TIE 1 Receptor Tyrosine Kinase
- TIE1 Tyrosine Kinase
- Tyrosine Kinase, TIE1
|
Below are MeSH descriptors whose meaning is more general than "Receptor, TIE-1".
Below are MeSH descriptors whose meaning is more specific than "Receptor, TIE-1".
This graph shows the total number of publications written about "Receptor, TIE-1" by people in this website by year, and whether "Receptor, TIE-1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptor, TIE-1" by people in Profiles.
-
Circulating DNA biomarkers: a primer for metastatic colorectal cancer? Lancet Oncol. 2015 Aug; 16(8):878-9.
-
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia. Cancer. 2002 Mar 01; 94(5):1517-21.
-
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome. Leuk Lymphoma. 2001 Jul; 42(3):511-6.
-
Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL). Leuk Res. 2001 Apr; 25(4):279-85.